Busulfan and Fludarabine as Conditioning for Allogeneic Stem Cell Transplantation: a Pharmacokinetic Study

Official Title

Busulfan and Fludarabine as Conditioning for Allogeneic Stem Cell

Summary:

A study of pharmacokinetics of daily intravenous busulfan

Trial Description

Primary Outcome:

  • pharmacokinetic data
A study of pharmacokinetics of daily intravenous busulfan

View this trial on ClinicalTrials.gov

Interested in this trial?

Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.

Resources

Canadian Cancer Society

These resources are provided in partnership with the Canadian Cancer Society